Melanoma is a heterogeneous tumor in which phenotype-switching and CD133 marker have been associated with metastasis promotion and chemotherapy resistance. CD133 positive (CD133+) subpopulation has also been suggested as putative cancer stem cell (CSC) of melanoma tumor. Human endogenous retrovirus type K (HERV-K) has been described to be aberrantly activated during melanoma progression and implicated in the etiopathogenesis of disease. Earlier, we reported that stress-induced HERV-K activation promotes cell malignant transformation and reduces the immunogenicity of melanoma cells. Herein, we investigated the correlation between HERV-K and the CD133+ melanoma cells during microenvironmental modifications.

Argaw Denboba, A., Balestrieri, E., Serafino, A., Cipriani, C., Bucci, I., Sorrentino, R., et al. (2017). HERV-K activation is strictly required to sustain CD133+ melanoma cells with stemness features. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 36(1), 20 [10.1186/s13046-016-0485-x].

HERV-K activation is strictly required to sustain CD133+ melanoma cells with stemness features

BALESTRIERI, EMANUELA;CIPRIANI, CHIARA;BUCCI, ILARIA;SORRENTINO, ROBERTA;GAMBACURTA, ALESSANDRA;SINIBALDI VALLEBONA, PAOLA;MATTEUCCI, CLAUDIA
2017-01-01

Abstract

Melanoma is a heterogeneous tumor in which phenotype-switching and CD133 marker have been associated with metastasis promotion and chemotherapy resistance. CD133 positive (CD133+) subpopulation has also been suggested as putative cancer stem cell (CSC) of melanoma tumor. Human endogenous retrovirus type K (HERV-K) has been described to be aberrantly activated during melanoma progression and implicated in the etiopathogenesis of disease. Earlier, we reported that stress-induced HERV-K activation promotes cell malignant transformation and reduces the immunogenicity of melanoma cells. Herein, we investigated the correlation between HERV-K and the CD133+ melanoma cells during microenvironmental modifications.
2017
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore MED/07 - MICROBIOLOGIA E MICROBIOLOGIA CLINICA
English
Con Impact Factor ISI
CD133; Cancer stem cell; HERV-K; Melanoma; Microenvironment; Retroelements
Argaw Denboba, A., Balestrieri, E., Serafino, A., Cipriani, C., Bucci, I., Sorrentino, R., et al. (2017). HERV-K activation is strictly required to sustain CD133+ melanoma cells with stemness features. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 36(1), 20 [10.1186/s13046-016-0485-x].
Argaw Denboba, A; Balestrieri, E; Serafino, A; Cipriani, C; Bucci, I; Sorrentino, R; Sciamanna, I; Gambacurta, A; SINIBALDI VALLEBONA, P; Matteucci, C
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/173168
Citazioni
  • ???jsp.display-item.citation.pmc??? 35
  • Scopus 50
  • ???jsp.display-item.citation.isi??? 47
social impact